We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » White House Should Examine R&D Costs, Rep. Brown Says
White House Should Examine R&D Costs, Rep. Brown Says
April 29, 2005
A House Democrat wants the Bush Administration to conduct a study on pharmaceutical R&D costs, noting that the estimated costs of bringing a new drug to market may be inflated by as much as 750 percent.